Genetic Toxicology Testing Market to Grow at 8.34% hrough 2030F
Increasing demand for personalized
medicine is expected to drive the growth of global genetic toxicology testing
in the forecast period, 2026-2030.
According to TechSci Research report, “Genetic
Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2020-2030F”, Global Genetic Toxicology Testing Market was valued at USD 1.88 billion in 2024 and is expected to reach USD 3.02 billion by 2030 with a CAGR of 8.34% during the forecast period. This
can be ascribed to the increasing development of novel drugs and vaccines for
the treatment of chronic diseases. Additionally, growing application of genetic
toxicology testing in various end use industries like cosmetic, food and
others, especially in the developed countries in the North America and Europe,
is expected to create lucrative opportunities for the market growth in coming
years. Besides, increasing approval of novel drugs by regulatory bodies and
increasing investments by government, are further expected to support the
market growth.
Moreover, growing popularity of humanized mice model
in various biomedical research applications is expected to drive the market
growth in the coming years. Various grants and fundings are being offered to
companies, academic & research institutions who are working to develop
humanized mice models which accurately represent human responses to cancer and
different cancer therapies.
However, lack of trained professionals can restrict
the market growth. Similarly, the high cost associated with research and
development may hamper the genetic toxicology testing market
growth during the forecast period. Also, lack of in vitro models to study
complex endpoints and approval duration of the drug delivery process in
emerging countries, can further restrict the growth of global genetic toxicology testing market.
Besides, ethical concerns of testing on animals can further slowdown the market
growth, since various non-governmental organizations and animal care
committee’s raise a lot of concern regarding the same.
Browse over XX market data Figures
spread through XX Pages and an in-depth
TOC on "Genetic Toxicology Testing Market"
Global genetic toxicology testing market
can be segmented by component, by type, by application and by region.
Based on application,The cosmetics industry is
expected to fastest growing segment the genetic toxicology testing market during the forecast
period due to the increasing use of cosmetic products worldwide. Rising
disposable incomes, especially in developing and emerging economies, have led
to greater consumer spending on personal care and beauty products. This growth
in demand drives manufacturers to introduce a wide range of innovative
cosmetics, including skincare, makeup, and hair care items. Along with growing
consumer awareness about product safety and quality, regulatory bodies have
imposed stricter guidelines on cosmetics to ensure they are free from harmful
substances. Genetic toxicology testing plays a crucial role in evaluating the
safety of cosmetic ingredients, helping companies comply with these regulations
and protect consumer health. Additionally, the easy availability and
accessibility of cosmetics through various retail channels, including online
platforms, contribute to market expansion. As a result, the cosmetics segment
is projected to maintain a dominant position by continuously adopting advanced
testing technologies to meet safety standards and consumer expectations.
Based on region, The Asia-Pacific region is the
fastest-growing market for genetic toxicology testing due to several key
factors. Rapid economic growth and increasing disposable incomes in countries
like China, India, and Japan are driving demand for pharmaceuticals, cosmetics,
and chemicals, all of which require rigorous safety testing. Expanding
pharmaceutical and biotechnology industries in the region are investing heavily
in research and development, boosting the need for advanced genetic toxicology
services. Regulatory authorities in Asia-Pacific are also strengthening safety
guidelines and adopting global testing standards, which compels manufacturers
to conduct comprehensive genotoxicity assessments. The growing public awareness
about product safety and environmental concerns encourages companies to
prioritize toxicology testing. Investments in healthcare infrastructure,
coupled with rising collaborations between local firms and global companies,
enhance technical capabilities and access to cutting-edge testing technologies.
These factors collectively create a conducive environment for rapid market
expansion, positioning Asia-Pacific as a leading growth hub in the genetic
toxicology testing industry.
Major companies operating in
global genetic toxicology testing market are:
·
Thermo Fisher Scientific, Inc.
·
Eurofins Scientific SE
·
Jubilant Life Sciences Limited
·
Syngene International Limited
·
Gentronix Ltd.
·
Inotiv Inc.
·
Charles River Laboratories
International, Inc.
·
Merck KGaA
·
Toxikon Corporation
·
Gentronix Limited
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“Rising drug development activities are a significant driver of the global genetic toxicology testing market. As pharmaceutical and biotechnology companies strive to develop innovative therapies, especially for complex diseases such as cancer, neurological disorders, and rare genetic conditions, the need for comprehensive safety assessments has grown exponentially. Genetic toxicology testing plays a pivotal role in early-stage drug development by identifying substances that could cause mutations, chromosomal damage, or other forms of genetic instability. These tests help researchers eliminate potentially harmful compounds before they progress to costly and time-consuming clinical trials. With the increasing complexity of drug candidates, including biologics, gene therapies, and cell-based treatments, genetic toxicology has become more critical than ever in ensuring patient safety and regulatory compliance”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research based global management
consulting firm.
“Genetic Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Component (Reagents & Consumables, Assays, Services), By Type (In Vitro v/s In Vivo), By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others), By
Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global genetic toxicology testing market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global genetic toxicology testing market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com